Obesity and prostate cancer mortality

Future Oncology

Volumn 3, Issue 5, 2007, Pages 557-567

  Kristal, Alan R ^a,b   Gong, Zhihong ^c  

^a UNIVERSITY OF WASHINGTON   (United States)

^b School of Public Health and Community Medicine   (United States)

^c Fred Hutchinson Cancer Research Center   (United States)

Author keywords

Incidence; Mortality; Obesity; Outcomes; Prostate cancer

Indexed keywords

BEHAVIOR MODIFICATION; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER RECURRENCE; CANCER RISK; DISEASE ASSOCIATION; HUMAN; METASTASIS; OBESITY; OUTCOME ASSESSMENT; PATIENT COUNSELING; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RECURRENCE RISK; REVIEW; RISK REDUCTION; WEIGHT REDUCTION;

HUMANS; MALE; OBESITY; PROSTATIC NEOPLASMS;

EID: 35348988241     PISSN: 14796694     EISSN: 17448301     Source Type: Journal    
DOI: 10.2217/14796694.3.5.557     Document Type: Review

References (41)

1. Buschemeyer W, Freedland SJ: Obesity and prostate cancer: epidemiology and clinical implications. Eur. Urol., 52, 331-343 (2007).
2. Snowdon DA, Phillips RL, Choi W: Diet, obesity, and risk of fatal prostate cancer. Am. J. Epidimiol. 120, 244-250 (1984).
3. Andersson SO, Wolk A, Bergstrom RB et al.: Body size and prostate cancer: a 20-year follow-up study among 135,006 Swedish construction workers. J. Natl Cancer Inst. 89, 385-389 (1997).
4. Rodriguez C, Patel AV, Calle EE, Jacobs EJ, Chao A, Thun MJ: Body mass index, height, and prostate cancer mortality in two large cohorts of adult men in the United States. Cancer Epidemiol. Biomarkers Prev. 10, 345-353 (2001).
5. Calle R, Rodriguez C, Walker-Thurmond K, Thun M: Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N. Engl. J. Med. 348, 1625-1638 (2003).
6. Wright ME, Chang SC, Schatzkin A et al.: Prospective study of adiposity and weight change in relation to prostate cancer incidence and mortality. Cancer 109, 675-684 (2007).
7. Giovannucci E, Liu Y, Platz EA, Stampfer MJ, Willett WC: Risk factors for prostate cancer incidence and progression in the Health Profressionals Follow-Up Study. Int. J. Cancer (2007) (Epub ahead of print).
8. Flegal KM, Carroll MD, Kuczmarski RJ, Johnson CL: Overweight and obesity in the United States: Prevalence and trends, 1960-1994. Int. J. Obes. 22, 39-47 (1998).
9. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM: Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 295, 1549-1555 (2006).
10. Kristal AR, Gong Z, Zeliadt S: Associations of obesity with prostate cancer risk, outcomes, and trends. Presented at: AACR International Conference on Frotiers in Cancer Prevention Research. Boston, MA, USA, November 12-15 (2006) (Abstract CS10-01).
11. MacInnis RJ, English DR. Body size and composition and prostate cancer risk: systematic review and meta-regression analysis. Cancer Causes Control 17, 989-1003 (2006).
12. Albertsen PC, Hanley JA, Fine J: 20-year outcomes following conservative management of clinically localized prostate cancer. JAMA 293, 2095-2101 (2005).
13. Tomioka S, Nakatsu H, Suzuki N, Murakami S, Matsuzaki O, Shimazaki JUN: Comparison of Gleason grade and score between preoperative biopsy and prostatectomy specimens in prostate cancer. Int. J. Urol. 13, 555-559 (2006).
14. Siddiqui SA, Inman BA, Sengupta S et al.: Obesity and survival after radical prostatectomy: a 10-year prospective cohort study. Cancer 107, 521-529 (2006).
15. Freedland SJ, Kane CJ, Amling CL, Aronson WJ, Terris MK, Presti JC: Upgrading and downgrading of prostate needle biopsy specimens: risk factors and clinical implications. Urology 69, 495-499 (2007).
16. Gong Z, Neuhouser ML, Goodman PJ et al.: Obesity, diabetes, and risk of prostate cancer: results from the Prostate Cancer Prevention Trial. Cancer Epidemiol. Biomarkers Prev. 15, 1977-1983 (2006).
17. Rodriguez C, McCullough ML, Mondul AM et al.: Meat consumption among black and white men and risk of prostate cancer in the Cancer Prevention Study II Nutrition Cohort. Cancer Epidemiol. Biomarkers Prev. 15, 211-216 (2006).
18. Littman AJ: Anthropometrics and prostate cancer risk. Am. J. Epidemiol. 165, 1271-1279 (2007).
19. Fowke JH, Signorello L, Underwood W, Ukoli FAM, Blot WJ: Obesity and prostate cancer screening among African-American and Caucasian men. Prostate 66, 1371-1380 (2006).
20. Fontaine KR, Heo M, Allison DB: Obesity and prostate cancer screening in the USA. Public Health 119, 694-698 (2005).
21. Kristal AR, Chi C, Tangen CM, Goodman PJ, Etzioni R, Thompson IM. Associations of demographic and lifestyle characteristics with prostate-specific antigen (PSA) concentration and rate of PSA increase. Cancer 106, 320-328 (2006).
22. Werny DM, Thompson T, Saraiya M et al.: Obesity is negatively associated with prostate-specific antigen in US men, 2001-2004. Cancer Epidemiol. Biomarkers Prev. 16, 70-76 (2007).
23. Nixon RG, Wener MH, Smith KM, Parson RE, Stobel SA, Brawer MK: Biological variation of prostate specific antigen levels in serum: an evaluation of day-to-day physiological fluctuations in a well-defined cohort of 24 patients. J. Urol. 157, 2183-2190 (1997).
24. Freedland SJ, Giovannucci E, Platz EA: Are findings from studies of obesity and prostate cancer really in conflict? Cancer Causes Control 17, 5-9 (2006).
25. Jhaveri FM, Zippe CD, Klein EA, Kupelian PA: Biochemical failure does not predict overall survival after radical prostatectomy for localized prostate cancer: 10-year results. Urology 54, 884-890 (1999).
26. Sandler HM, DeSilvio ML: Surrogate and points for prostate cancer: what is prostate-specific antigen telling us? J. Natl Cancer Inst. 95, 1352-1353 (200).
27. Amling CL: The association between obesity and the progression of prostate and renal cell carcinoma. Urol. Onco. 22, 478-484 (2004).
28. Freedland SJ, Terris MK, Presti JC Jr et al.: Obesity and biochemical outcome following radical prostatectomy for organ confined disease with negative surgical margins. J. Urol. 172, 520-524 (2004).
29. Bassett WW, Cooperberg MR, Sadetsky N et al.: Impact of obesity on prostate cancer recurrence after radical prostatectomy: data from CaPSURE. Urology 66, 1060-1065 (2005).
30. Freedland SJ, Aronson W, Kane CJ et al.: Impact of obesity on biochemical control after radical prostatectomy for clinically localized prostate cancer: a report by the Shared Equal Access Regional Cancer Hospital Database study group. J. Clin. Oncol. 22, 446-453 (2004).
31. Freedland SJ, Isaacs WB, Mangold LA et al.: Stronger association between obesity and biochemical progression after radical prostarectomy among men treated in the fast 10 years. Clin Cancer Res. 11, 2883-2888 (2005).
32. Freedland SJ, Grubb KA, Yiu SK et al.: Obesity and risk of biochemical progression following radical prostatectomy at a tertiary care referral center. J. Urol. 174, 919-922 (2005).
33. Mallah KN, DiBlasio CJ, Rhee AC, Scardino PT, Kattan MW: Body mass index is weakly associated with, and not a helpful predictor of, disease progression in men with clinically localized prostate carcinoma treated with radical prostatectomy. Cancer 103, 2030-2034 (2005).
34. Strom SS, Wang X, Pettaway CA et al.: Obesity, weight gain, and risk of biochemical failure among prostate cancer patients following prostatectomy. Clin. Cancer Res. 11, 6889-6894 (2005).
35. Chun FKH, Briganti A. Graefen M et al.: Body ma index does not improve the ability to predict biochemical recurrence after radical prostatectomy, Eur. J. Cancer 43, 375-382 (2007).
36. Merrick GS, Butler WM, Wallner KE et al.: influence of body mass index on biochemical outcome after permanent prostate brachytherapy. Urology 65, 95-100 (2005).
37. Strom SS, Kamat AM, Gruschkus SK et al.: Influence of obesity on biochemical and clinical failure after external-beam radiotherapy for localized prostate cancer. Cancer 107, 631-639 (2006).
38. Efstathiou JA, Chen MH, Renshaw AA, Loffredo MJ, D'Amico AV: Influence of body mass index on prostate-specific antigen failure after androgen suppression and radiation therapy for localized prostate cancer. Cancer 109, 1493-1498 (2007).
39. Chen H, Miller BA, Giovannucci E, Hayes RB: Height and the survival of prostate cancer patients. Cancer Epidemiol. Biomarkers Prev. 12, 215-218 (2003).
40. Gong Z, Agalliu I, Lin DW, Stanford JL, Kristal AR: Obesity is associated with increased risks of prostate cancer metastasis and death after initial cancer diagnosis in middle-aged men. Cancer 109, 1192-1202 (2007).
41. Ma J, Li H, Mucci L, Gaziano J, Stampfer M: A 23-year survival analysis of prediagnostic BMI and risk of lethal prostate cancer. Presented at: AACR International Conference on Frontiers in Cancer Prevention Research. Boston, MA, USA, November 12-15 (2006) (Abstract A205).